Anti-Interleukin-1 in Diabetes Action

NCT00711503 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: anakinra
DRUG: saline

Sponsor

Steno Diabetes Center Copenhagen

Collaborators

[object Object]
[object Object]